Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific to keep endosurgery biz

This article was originally published in The Gray Sheet

Executive Summary

Firm decides to forego divestiture of a minority stake in its $1.4 billion-in-sales endosurgery unit via an initial public stock offering, the firm announces Aug. 2. Boston Scientific ultimately decided selling a part of the endosurgery business to accelerate debt repayment, a move under consideration since March, "would have reduced, rather than enhanced, Boston Scientific's shareholder value," CEO Jim Tobin explains. Plans to sell non-strategic assets and reduce headcount to cut expenses are still in the works, however, and the firm suggests investors stay tuned for related announcements in the "coming weeks and months" (1"The Gray Sheet" July 30, 2007, p. 17)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT025094

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel